Clinical Pharmacology & Therapeutics · 2004 · 260 citations · 27 references
This study identified several UGT1A1 haplotypes significantly associated with the reduced AUC ratio (*28 and *6) and with the increased total bilirubin level (*28, *60, and *IB) and suggested that the novel haplotype *IB might be functionally important. These findings will be useful for further pharmacogenetic studies on adverse reactions to irinotecan.
27
Yukio Ando, Hideo Saka, Maki Ando et al. · PubMed · 2000 · 788 citations
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).
Ron H.J. Mathijssen, R J van Alphen, Jaco J. Verweij et al. · PubMed · 2001 · 752 citations
Cpt-11 Belongs, Chemoprevention Strategy, Pharmacotherapy +18